BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17112504)

  • 21. Delayed postoperative latent pain sensitization revealed by the systemic administration of opioid antagonists in mice.
    Campillo A; Cabañero D; Romero A; García-Nogales P; Puig MM
    Eur J Pharmacol; 2011 Apr; 657(1-3):89-96. PubMed ID: 21300053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of spinal release of α-neo-endorphin on the antinociceptive effect of TAPA.
    Mizoguchi H; Kon-No T; Watanabe H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S
    Peptides; 2013 Dec; 50():139-44. PubMed ID: 24126280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D-pro(2)-endomorphin-1 and D-pro(2)-endomorphin-2, respectively, attenuate the antinociception induced by endomorphin-1 and endomorphin-2 given intrathecally in the mouse.
    Hung KC; Wu HE; Mizoguchi H; Sakurada S; Okayama T; Fujimura T; Murayama K; Sakurada T; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 2002 Nov; 303(2):874-9. PubMed ID: 12388675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-constrained endomorphin analogs display differential antinociceptive mechanisms in mice after spinal administration.
    Wang Y; Zhou J; Liu X; Zhao L; Wang Z; Zhang X; Wang K; Wang L; Wang R
    Peptides; 2017 May; 91():40-48. PubMed ID: 28363796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala.
    Narita M; Kaneko C; Miyoshi K; Nagumo Y; Kuzumaki N; Nakajima M; Nanjo K; Matsuzawa K; Yamazaki M; Suzuki T
    Neuropsychopharmacology; 2006 Apr; 31(4):739-50. PubMed ID: 16123756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrathecal endomorphin-1 produces antinociceptive activities modulated by alpha 2-adrenoceptors in the rat tail flick, tail pressure and formalin tests.
    Hao S; Takahata O; Iwasaki H
    Life Sci; 2000 Mar; 66(15):PL195-204. PubMed ID: 11210721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone.
    Sakurada S; Hayashi T; Yuhki M; Fujimura T; Murayama K; Yonezawa A; Sakurada C; Takeshita M; Zadina JE; Kastin AJ; Sakurada T
    Brain Res; 2000 Oct; 881(1):1-8. PubMed ID: 11033087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of synchronous or asynchronous electroacupuncture stimulation with low versus high frequency on spinal opioid release and tail flick nociception.
    Wang Y; Zhang Y; Wang W; Cao Y; Han JS
    Exp Neurol; 2005 Mar; 192(1):156-62. PubMed ID: 15698629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
    Xu JY; Seyed-Mozaffari A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antitussive effects of endomorphin-1 and endomorphin-2 in mice.
    Kamei J; Morita K; Saitoh A; Nagase H
    Eur J Pharmacol; 2003 Apr; 467(1-3):219-22. PubMed ID: 12706478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different motivational effects induced by the endogenous mu-opioid receptor ligands endomorphin-1 and -2 in the mouse.
    Narita M; Ozaki S; Ioka M; Mizoguchi H; Nagase H; Tseng LF; Suzuki T
    Neuroscience; 2001; 105(1):213-8. PubMed ID: 11483313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation of opioid receptor preference by [Dmt1]endomorphin-2-mediated antinociception in the mouse.
    Jinsmaa Y; Fujita Y; Shiotani K; Miyazaki A; Li T; Tsuda Y; Okada Y; Ambo A; Sasaki Y; Bryant SD; Lazarus LH
    Eur J Pharmacol; 2005 Feb; 509(1):37-42. PubMed ID: 15713427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test.
    Lutfy K; Maidment NT
    Br J Pharmacol; 2000 Dec; 131(8):1684-8. PubMed ID: 11139447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antinociceptive properties of oxymorphazole in the mouse.
    Wu HE; Sun HS; Darpolar M; Dunn W; Tseng LF
    Eur J Pharmacol; 2003 Jul; 473(2-3):143-8. PubMed ID: 12892831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of spinal mu1-opioid receptors on the Tyr-d-Arg-Phe-sarcosine-induced antinociception.
    Mizoguchi H; Nakayama D; Watanabe H; Ito K; Sakurada W; Sawai T; Fujimura T; Sato T; Sakurada T; Sakurada S
    Eur J Pharmacol; 2006 Jul; 540(1-3):67-72. PubMed ID: 16730704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray.
    Tershner SA; Helmstetter FJ
    Brain Res; 2000 May; 865(1):17-26. PubMed ID: 10814729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endomorphin-2 and endomorphin-1 promote the extracellular amount of accumbal dopamine via nonopioid and mu-opioid receptors, respectively.
    Okutsu H; Watanabe S; Takahashi I; Aono Y; Saigusa T; Koshikawa N; Cools AR
    Neuropsychopharmacology; 2006 Feb; 31(2):375-83. PubMed ID: 16034447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of endomorphin-2-induced analgesia by dipeptidyl peptidase IV.
    Shane R; Wilk S; Bodnar RJ
    Brain Res; 1999 Jan; 815(2):278-86. PubMed ID: 9878785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microinfusion of mu but not delta or kappa opioid agonists into the basolateral amygdala results in inhibition of the tail flick reflex in pentobarbital-anesthetized rats.
    Helmstetter FJ; Bellgowan PS; Poore LH
    J Pharmacol Exp Ther; 1995 Oct; 275(1):381-8. PubMed ID: 7562575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.